Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Second Quarter 2025 Financial Results Conference Call.
Inovio Pharmaceuticals Inc. (INO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 1,981,370 | $4,032,088 | -37% | 0.13% |
| 2. | Millennium Management Israel Englander | 346,865 | $705,870 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 328,129 | $667,743 | +617% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 168,956 | $343,825 | 0% | |
| 5. | GMT Capital Thomas E. Claugus | 126,119 | $256,652 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.11 | 22,500 | $69,975.00 | 1,100,707 | 2020-01-13 | Filing | |
| $2.22 | 4,500 | $9,990.00 | 50,333 | 2019-08-30 | Filing | |
| $2.50 | 20,000 | $50,000.00 | 45,833 | 2019-06-05 | Filing | |
| $6.25 | 21,300 | $133,188.90 | 50,000 | 2017-03-27 | Filing | |
| $9.13 | 10,000 | $91,309.00 | 142,291 | 2016-06-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.56 | 5,700 | $3,192.00 | 52,716 | 2023-06-05 | Filing | |
| $1.15 | 5,833 | $6,707.95 | 910,124 | 2023-03-13 | Filing | |
| $1.28 | 11,668 | $14,935.04 | 904,291 | 2023-02-27 | Filing | |
| $2.66 | 11,875 | $31,587.50 | 892,625 | 2022-08-11 | Filing | |
| $2.25 | 2,000 | $4,500.00 | 75,305 | 2022-07-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,009,145 | $4,088,610 | 0% | |
| 2. | 1,270,607 | $2,585,685 | 0% | |
| 3. | 537,628 | $1,094,072 | 0% | |
| 4. | 437,549 | $890,622 | 0% | |
| 5. | 401,862 | $817,792 | 0% |
News See All
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio First Quarter 2025 Financial Results Conference Call. At this time all participants are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2024 Financial Results Conference Call. At this time, all lines are in listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Third Quarter 2024 Financial Results Conference Call. At this time, all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2024 Earnings Call Transcript
Operator: Good afternoon ladies and gentlemen and welcome to the Inovio Second Quarter 2024 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the INOVIO First Quarter 2024 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Inovio Third Quarter 2023 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Inovio Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2023 Earnings Call Transcript
Operator: Good day and welcome to the Inovio First Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode for the duration of the call.
Billionaire Hedge Funds
